
We Doc Pharmaceuticals Private Limited
About We Doc Pharmaceuticals Private Limited
Data last updated:
We Doc Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 27 October 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL1998PTC096832. Its GSTIN is 07AAACW2511K1ZH (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.86 Lakh. It is led by directors Nagendra Kumar Sinha and Manoj Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.85 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹59,247 (net margin -3.5%) and EBITDA of -₹57,725 (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
We Doc Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of We Doc Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of We Doc Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of We Doc Pharmaceuticals Private Limited, buy the company report.
Financials of We Doc Pharmaceuticals Private Limited
FY 2025 filings availableWe Doc Pharmaceuticals Private Limited reported revenue of ₹16.85 Lakh (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57,725 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹59,247 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.4% | ||||
| Net Profit Margin | -3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of We Doc Pharmaceuticals Private Limited, buy the company report.
Board of directors of We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagendra Kumar Sinha Also directs: Shanti Niketan Buildtech Private Limited, Shanti Niketan Buildcon Private Limited, Educity Pedagogy Private Limited and 1 more | Director | 27 Oct 1998 | 28 Years 0 Months | Current |
| Manoj Kumar | Director | 27 Oct 1998 | 28 Years 0 Months | Current |
Peer comparison
We Doc Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anoush Pharmaceuticals India Private Limited | ₹16.94 Lakh (FY 2023) | 21.0% | Hoshiarpur, Punjab, India | |||
| We Doc Pharmaceuticals Private Limitedthis company | ₹16.85 Lakh (FY 2025) | -₹59,247 | -3.5% | -38.0% | Delhi, India | |
| Shirama Pharmaceuticals Private Limited | ₹16.84 Lakh (FY 2024) | 85.0% | Varanasi, Uttar Pradesh, India | |||
| Turio Pharmaceuticals Private Limited | ₹16.81 Lakh (FY 2024) | 1265.0% | Hyderabad, Telangana, India |
To see the full peer comparison of We Doc Pharmaceuticals Private Limited, buy the company report.
Auditor
We Doc Pharmaceuticals Private Limited is audited by UKS & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UKS & ASSOCIATES | FY 2017 | 013015N |
Shareholding
The shareholding of We Doc Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of We Doc Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving We Doc Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for We Doc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
We Doc Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW2511K1ZH | Delhi | Active | 01 Jul 2017 |
| 24AAACW2511K1ZL | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of We Doc Pharmaceuticals Private Limited, buy the company report.
Recent activity
We Doc Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Manoj Kumar was appointed as Director on 27 Oct 1998.
Frequently asked questions
We Doc Pharmaceuticals is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 27 October 1998 (28+ years old) and is registered under CIN U24233DL1998PTC096832.
We Doc Pharmaceuticals has 2 current directors:
- Nagendra Kumar Sinha - Director
- Manoj Kumar - Director
The latest financial statements of We Doc Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of We Doc Pharmaceuticals is 07AAACW2511K1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACW2511K1ZL (Gujarat).
The CIN (Corporate Identification Number) of We Doc Pharmaceuticals is U24233DL1998PTC096832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
We Doc Pharmaceuticals was incorporated on 27 October 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of We Doc Pharmaceuticals by revenue are Anoush Pharmaceuticals India Private Limited, Shirama Pharmaceuticals Private Limited, Turio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Manoj Kumar was appointed as Director on 27 Oct 1998. Nagendra Kumar Sinha was appointed as Director on 27 Oct 1998.
The registered office of We Doc Pharmaceuticals is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.
We Doc Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of We Doc Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.

